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Many  factors  influence  our  susceptibility  to  disease.  These 
include our stress load, our environment and the toxins we absorb from it, 
the total number of infectious agents we are exposed to as well as our 
underlying genetic susceptibility to these diseases. 
Multifactorial  is  the  term  given  to  the  mode  of  transmission 
shown by a large number of diseases which show familial clustering but 
which  is  not  in  accord  with  any  recognized  pattern  of  single  gene 
inheritance.  These  diseases  include  several  common  congenital 
malformations  and acquired  disorders  of  childhood  and  adult  life.  The 
underlying  genetic  mechanism  is  thought  to  involve  interaction  of 284  GENETIKA, Vol. 39, No. 2, 283-290, 2007. 
relatively large numbers of genes – hence oligogenic or polygenic – with 
environmental factors. 
The ultimate cause of Alzheimer’s (AD) is unknown. Genetic 
factors are  suspected,  and  dominant  mutations in  three  different  genes 
have been identified that account for a much smaller number of cases of 
familial, early –onset AD. For the more form of late onset AD, ApoE is 
the only repeatedly confirmed susceptibility gene. 
Coronary  artery  disease  is  well-recognized  complication  of 
several single-gene disorders involving lipid metabolism. Over 20 genes 
have been proposed as candidates for polygenic coronary artery disease. 
These  include  genes  which  control  lipid  metabolism,  blood  pressure, 
clotting, and fibrinolysis. 
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INTRODUCTION 
The  risk  of  many  common  diseases  is  thought  to  be  influenced  by 
multiple  genes  as  well  as  environmental  factors  (BRIEN  et  al.  2000).  These 
complex  diseases  include  asthma,  diabetes,  epilepsy,  hypertension,  manic 
depression and schizophrenia (LAITINEN et al. 2001, LAITINEN et al. 2004). Certain 
developmental abnormalities are also included in this category, such as cleft lip/ 
palate, congenital heart defects and neural tube defects (TAIPALE 2003). 
Complex  diseases  have  a  low  heritability  compared  to  single  gene 
disordes. For example, only  2-5 per cent of the close relatives of diabetes also 
suffer from diabetes, much lower than would be case for a single gene disorder like 
cystic fibrosis. This indicates that no single genetic factor is responsible for the 
disease. Many factors influence our susceptibility to disease. These include our 
stress load, our environment and the toxins we absorb from it, the total number of 
infectious agents we are exposed to as well as our underlying genetic susceptibility 
to  these  diseases.    It  is  thought  that  the  incidence  of  any  complex  disease  is 
dependent on a balance of risks. There is a balance between gene variants with 
positive and negative effects, and between environmental factors with positive and 
negative effects. Too many negative factors, both genetic and environmental, can 
tip the balance towards disease (KERE et al. 1996).  
In general the disordes that fall into this category can be divided into two 
groups:  those  that  present  at  birth  or  early  childhood,  such  as  non-syndromal 
cardiac defects and Hirschsprung disease, and those that occur in later life, such as 
diabetes mellitus and schizophrenia.  
  Despite  extensive  research,  the  underlying  molecular  pathogenesis  of 
most of these disordes remains unclear. Generally the prevailing evidence points to 
a complex and poorly understood interaction between genes at more than one locus 
with  environmental  factors  that  may  be  involved  before  or  after  birth.  S. PAJOVIC: POLYGENIC AND MILTUFACTORIAL DISORDES                                               285 
Multifactorial inheritance is suspected on the basis of family, twin, and adoption 
studies. 
 
Approaches to finding susceptibility genes 
The identification of genes which contribute to multifactorial disorders is 
an area of intense activity amongst the scientific community, where vast amounts 
are  being  invested  by  the  research  funding  bodies  and  by  the  pharmaceutical 
industry. The goal is to identify genes which play an important role in conveying 
susceptibility to the common disorders of adult life with a view to developing tests 
for  their  preclinical  detection  and  new  genetically  based  approaches  for  their 
prevention and treatment. Unfortunately, progress to date has been very limited. 
Three main strategies have been applied: linkage analysis, association studies, and 
linkage disequilibrium (TOIVONEN 2000). 
 
Examples of multifactorial disorders  
Present at birth or onset in infancy  Acquired with onset in childhood or adulthood 
Cardiac defects, e.g. atrial septal 
defect, tetralogy of Fallot 
Ventricular septal defect 
Alzheimer disease 
Cleft lip/ palate                                           Asthma 
Congenital dislocation of the hip                Autism 
Hirchsprung disease  Coronary artery disease 
Neuronal tubes defects  Depression – unipolar and bipolar 
Pyloric stenosis  Diabetes mellitus – types1 and 2 
Talipes  Hypertension 
  Inflammatory bowel  disease, Crohn disease and 
ulcerative colitis                                            
  Schizophrenia   
Alzheimer’s disease 
Alzheimer’s disease (AD) is the most frequent type of dementia in the 
elderly and affects almost half of all patients with dementia. Clinically it manifests 
as  progressive  loss  of  memory,  emotional  disturbance,  and  loss  of  intellectual 
skills. Alzheimer’s disease has been identified as a protein misfolding disease, or 
proteopathy, due to the accumulation of abnormally folded amyloid beta protein 
and  tau  protein  in  the  brains  of  AD  patients  (KERR  and  SMALL  2005).  The 
neuropathological  findings  consist  of  neurofibrillary  tangles  made  up  of  tau 
protein,  which  are  neurotoxic,  and  senile  plaques  consisting  of  amyloid  fibres 
known as AB which are derived from amyloid precursor protein (APP) (YANKER et 
al. 1990, OHNISHI and TAKANO 2004). 
Rare  cases  of  Alzheimer’s  are  caused  by  dominant  genes  that  run  in 
families.  These  cases  often  have  an  early  age  of  onset.  The  first  gene  to  be 
implicated  was  APP  on  chromosome  21.  This  encodes  the  amyloid  precursor 
protein.  The small number of mutations identified in APP lead to an increase in 286  GENETIKA, Vol. 39, No. 2, 283-290, 2007. 
production  of  APP  and  hence  AB,  this  being  the  chief  constituent  of  the 
characteristic  senile  plaques.  This  observation  is  thought  to  explain  the  high 
incidence  of  Alzheimer  disease  seen  in  older  adults  with  Down  syndrome 
(TIRABOSCHI et al. 2004, LOTT and HEAD 2005). 
Linkage analysis identified susceptibility loci on chromosomes 14 and 1 
where genes known as Presenilin-1 (PS1) and Presenilin-2 (PS2) were isolated. 
PS1  and  PS2  are  thought  to  act  by  enhancing  APP  processing,  leading  to 
overproduction of AB which in turn leads to the formation of senile plaques and 
neurofibrillary tangles (WANG et al. 2004, CAI et al. 2006, VETRIVEL et al. 2006). 
     
                                                             APP 
                                                         mutations 
 
                                                                  
                      Down                Presenilin   
                     Syndrome             mutations 
                                       
       
                                                                                               
                                                                                           
                           Overproduction of  amyloid fibres 
                
 
             
 
 
                                                        Senile plaques 
                        
 
        
              Inflammatory                                                          Neurofibrillary                                                                         
                    response                                                            tangles 
                          
   
                                Neuronal death 
 
Fig.1. Simplifed diagram to explain the pathogenesis of Alzheimer’s disease. 
   Adapted from McGuffin P, Owen MJ, Gottesman II(2002) Psychiatric                            
genetics and genomics.Oxford University Press, Oxford. 
 
Also, linkage analysis in families focused attention on chromosome 19 
where a polymorphism at the APOE locus was found to show a strong association 
with late-onset Alzheimer disease. Apolipoprotein E (ApoE) is synthesized in the 
liver and brain and is involved in lipid metabolism and tissue repair There are three 
common alleles at the APOE locus: E2, E3, and E4. The frequency of the E4 allele S. PAJOVIC: POLYGENIC AND MILTUFACTORIAL DISORDES                                               287 
is significantly increased in patients with Alzheimer disease, to the extent that the 
odds  ratio  for  developing  Alzheimer  disease  is  increased  12-fold  for  E4E4 
homozygotes  as  compared  with  E3E3  homozygotes.  The  lifetime  risk  for 
developing Alzheimer disease being around 35% for E4E4 men and 50% for E4E4 
women (POLVIKOSKI et al. 1995).   
Thus, the ultimate cause of Alzheimer’s is unknown. Genetic factors are 
suspected, and dominant mutations in three different genes have been identified 
that account for a much smaller number of cases of familial, early –onset AD. For 
the  more  form  of  late  onset  AD,  ApoE  is  the  only  repeatedly  confirmed 
susceptibility gene (MANEV H. and MANEV R. 2006). 
 
Coronary artery disease 
 
Failure to compensate for the deleterious effects of various factors may result in 
development of different pathophysiologies in the cardiovascular system, such as, 
ischemia,  hypertension,  atherosclerosis  and  infarction  (PAJOVIĆ  et  al.1999,  
KANAZIR et al. 2004). The general picture of the molecular mechanisms of the 
induced pathophysiology in the CVS pointed out the importance of stress duration 
and intensity as etiological factors, and suggested that future studies should  be 
complemented by the careful insights into the individual factors of susceptibility to 
stress,  prophylactic  effects  of  'healthy'  life  styles  and  beneficial  action  of 
antioxidant rich nutrition (FINKEL 1998, ALLEn 1998, ALLEN and TRESINI 2000). 
Coronary artery disease is well-recognized complication of several single-
gene disorders involving lipid metabolism (HOLVOET 1999). Over 20 genes have 
been  proposed  as  candidates  for  polygenic  coronary  artery  disease  (HUANG  et 
al.1993, IMBERT et al. 1996, ISHII et al. 1997).  These include genes which control 
lipid metabolism, blood pressure, clotting, and fibrinolysis (KARIN and HUNTER 
1995, KONISHI et al. 1997).  One particular polymorphism which has been studied 
at length is that of an insertion (I)/deletion (D) in intron 16 of ACE, the gene which 
encodes the enzyme which converts angiotensin I into angiotensin II (CARMINE 
and ERNESTO 2007). Homozygotes for the DD genotype have higher plasma and 
tissue levels of the enzyme than those with the ID or II genotype. They also show a 
higher incidence of coronary artery disease, with one study suggesting that in the 
absence of other risk factors such as smoking, hypertension, diabetes, and obesity, 
the  ACE  DD  genotype  accounts  for  35%  of  cases  of  myocardial  infraction 
(PARTHASARATHY et al. 2001, FANG et al. 2002). 
Finally, it is essential that we take advantage of the strides that have been 
made  in  the  human  genome  project  to  understand  our  underlying  genetic 
susceptibilities  as  well  as  the  infectious  and  environmental  components  that 
compromise  disease  states  (BOSMA et al.  1998,  PAJOVIĆ 2007,  PHEGLEY  et  al. 
2002). 
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I z v o d 
 
Izučavanja etiopatogeneze mnogih obolenja ukazuju na izuzetnu složenost 
molekularnih mehanizama, s obzirom da pored genetskih faktora, faktori sredine 
značajno  utiču  na  njihovu  fenotipsku  ekspresiju.  Poligensko  nasleđivanje  uz 
sadejstvo faktora spoljašnje sredine naziva se multifaktorsko nasleđivanje. 
Mnoge bolesti se nasleđuju multifaktorski, kao što su dijabetes, epilepsija, 
shizofrenija, Alzheimer-ova bolest , reumatoidni artritis, arterijska hipertenzija, čir 
na želucu, kao i urođene anomalije dece: rascep usne i nepca, iščašenje kukova, 
defekt nervne cevi i dr. 
Multifaktorske bolesti i tip njihovog nasleđivanja je veoma teško pratiti, 
jer ne podležu pravilnostima prenošenja unutar porodice, zbog očiglednog uticaja 
činilaca sredine na ispoljavanje poligena. 
Poligensko nasleđivanje Alzheimer-ove bolesti javlja se posle 65 godine. 
Linkage analiza je u ovim familijama fokusirala pažnju na hromozom 19, gde je 
uočen polimorfizam lokusa APOE , koji je u strogoj asocijaciji sa kasnom pojavom 
bolesti.   
       Preko 20 gena su kandidati za poligenska koronarna arterijska obolenja. Geni 
su  uključeni  u  metabolizam  lipida,  krvni  pritisak,  zgrušavanje  i  fibrinolizu; 
posebno je izučavan  ACE gen, koji kodira enzim za prevođenje angiotenzina I u 
angiotenzin II. 
U  razjašnjavanju  molekularnih  mehanizama  nastanka  i  prenošenja 
multifaktorskih bolesti, veoma je važno identifikovati faktore spoljne sredine, koji 
inter-reaguju sa genetskom osetljivošću i značajno je modifikuju.  
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